Literature DB >> 16413785

New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies.

Ramy Farid1, Tyler Day, Richard A Friesner, Robert A Pearlstein.   

Abstract

We created a homology model of the homo-tetrameric pore domain of HERG using the crystal structure of the bacterial potassium channel, KvAP, as a template. We docked a set of known blockers with well-characterized effects on channel function into the lumen of the pore between the selectivity filter and extracellular entrance using a novel docking and refinement procedure incorporating Glide and Prime. Key aromatic groups of the blockers are predicted to form multiple simultaneous ring stacking and hydrophobic interactions among the eight aromatic residues lining the pore. Furthermore, each blocker can achieve these interactions via multiple docking configurations. To further interpret the docking results, we mapped hydrophobic and hydrophilic potentials within the lumen of each refined docked complex. Hydrophilic iso-potential contours define a 'propeller-shaped' volume at the selectivity filter entrance. Hydrophobic contours define a hollow 'crown-shaped' volume located above the 'propeller', whose hydrophobic 'rim' extends along the pore axis between Tyr652 and Phe656. Blockers adopt conformations/binding orientations that closely mimic the shapes and properties of these contours. Blocker basic groups are localized in the hydrophilic 'propeller', forming electrostatic interactions with Ser624 rather than a generally accepted pi-cation interaction with Tyr652. Terfenadine, cisapride, sertindole, ibutilide, and clofilium adopt similar docked poses, in which their N-substituents bridge radially across the hollow interior of the 'crown' (analogous to the hub and spokes of a wheel), and project aromatic/hydrophobic portions into the hydrophobic 'rim'. MK-499 docks with its longitudinal axis parallel to the axis of the pore and 'crown', and its hydrophobic groups buried within the hydrophobic 'rim'.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16413785     DOI: 10.1016/j.bmc.2005.12.032

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  97 in total

1.  Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo.

Authors:  Albert A De Vera; Pranav Gupta; Zining Lei; Dan Liao; Silpa Narayanan; Qiuxu Teng; Sandra E Reznik; Zhe-Sheng Chen
Journal:  Cancer Lett       Date:  2018-11-01       Impact factor: 8.679

2.  Regorafenib antagonizes BCRP-mediated multidrug resistance in colon cancer.

Authors:  Yun-Kai Zhang; Yi-Jun Wang; Zi-Ning Lei; Guan-Nan Zhang; Xiao-Yu Zhang; De-Shen Wang; Sweilem B Al-Rihani; Suneet Shukla; Suresh V Ambudkar; Amal Kaddoumi; Zhi Shi; Zhe-Sheng Chen
Journal:  Cancer Lett       Date:  2018-10-28       Impact factor: 8.679

3.  Cardio-vascular safety beyond hERG: in silico modelling of a guinea pig right atrium assay.

Authors:  Luca A Fenu; Ard Teisman; Stefan S De Buck; Vikash K Sinha; Ron A H J Gilissen; Marjoleen J M A Nijsen; Claire E Mackie; Wendy E Sanderson
Journal:  J Comput Aided Mol Des       Date:  2009-11-05       Impact factor: 3.686

4.  Mapping Ryanodine Binding Sites in the Pore Cavity of Ryanodine Receptors.

Authors:  Van A Ngo; Laura L Perissinotti; Williams Miranda; S R Wayne Chen; Sergei Y Noskov
Journal:  Biophys J       Date:  2017-04-25       Impact factor: 4.033

Review 5.  Computational methods of studying the binding of toxins from venomous animals to biological ion channels: theory and applications.

Authors:  Dan Gordon; Rong Chen; Shin-Ho Chung
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

6.  ADMET evaluation in drug discovery. 12. Development of binary classification models for prediction of hERG potassium channel blockage.

Authors:  Sichao Wang; Youyong Li; Junmei Wang; Lei Chen; Liling Zhang; Huidong Yu; Tingjun Hou
Journal:  Mol Pharm       Date:  2012-03-16       Impact factor: 4.939

7.  Activation of atypical protein kinase C by sphingosine 1-phosphate revealed by an aPKC-specific activity reporter.

Authors:  Taketoshi Kajimoto; Alisha D Caliman; Irene S Tobias; Taro Okada; Caila A Pilo; An-Angela N Van; J Andrew McCammon; Shun-Ichi Nakamura; Alexandra C Newton
Journal:  Sci Signal       Date:  2019-01-01       Impact factor: 8.192

8.  Molecular determinants of hERG channel block by terfenadine and cisapride.

Authors:  Kaichiro Kamiya; Ryoko Niwa; Mikio Morishima; Haruo Honjo; Michael C Sanguinetti
Journal:  J Pharmacol Sci       Date:  2008-11-06       Impact factor: 3.337

9.  Modeling MEK4 Kinase Inhibitors through Perturbed Electrostatic Potential Charges.

Authors:  Rama K Mishra; Kristine K Deibler; Matthew R Clutter; Purav P Vagadia; Matthew O'Connor; Gary E Schiltz; Raymond Bergan; Karl A Scheidt
Journal:  J Chem Inf Model       Date:  2019-10-14       Impact factor: 4.956

10.  In vitro and in silico evaluation of the inhibitory effect of a curcumin-based oxovanadium (IV) complex on alkaline phosphatase activity and bacterial biofilm formation.

Authors:  G Katsipis; V Tsalouxidou; E Halevas; E Geromichalou; G Geromichalos; A A Pantazaki
Journal:  Appl Microbiol Biotechnol       Date:  2020-11-16       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.